GEODE CAPITAL MANAGEMENT, LLC - CADENCE PHARMACEUTICALS INC ownership

Back to all holdings Add to watchlist

CADENCE PHARMACEUTICALS INC's ticker is CADX and the CUSIP is 12738T100. A total of 90 filers reported holding CADENCE PHARMACEUTICALS INC in Q3 2013. The put-call ratio across all filers is 3.58 and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of CADENCE PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2013$3,070,000
+85.2%
339,252
+29.1%
0.00%
+100.0%
Q3 2013$1,658,000
+2.2%
262,704
+10.4%
0.00%0.0%
Q2 2013$1,623,000–237,920–0.00%–
 Download
Other shareholders

There were no reported owners of CADENCE PHARMACEUTICALS INC in Q3 2013.

NameSharesValueWeighting ↓
View complete list of CADENCE PHARMACEUTICALS INC shareholders